Connect
← Return to Just approved: Evusheld for the pre-exposure prevention of COVID-19
Discussion
Just approved: Evusheld for the pre-exposure prevention of COVID-19
Transplants | Last Active: Aug 19, 2022 | Replies (173)Comment receiving replies
I had a huge problem with my PCP and my nephrologist with getting referrals for antibodies testing and Regeneron infusion. I think they are following the insurance recommendations and not the CDC recommendation. It took me over 2months to finally get a referral for Regeneron even though I met the criteria. I informed my nephrologist of EVUSHELD and after researching it, I was told that it with be in high demand and will be authorized based on priority of need or those more immunocompromised first. Keep in mind that the doctors are as overwhelmed as we are with all of the changes. They don’t have time to read the CDC reviews daily. There are hospital and insurance guidelines that they are required to follow.
Replies to "I had a huge problem with my PCP and my nephrologist with getting referrals for antibodies..."
Our State Health Commission office has authorized it for immunosuppressed people. So, you might contact them directly.
Connect
They are a distributor of life saving monoclonals. Someone has read the criteria. A memo can inform all PCP's of the CDC guidelines and the Mayo Clinics guidelines. The PCP can tell the patient they do not currently meet Mayo Clinics guidelines due to short supply. I was told I didn't meet the criteria because I tolerated the vaccines and was not allergic to it. There was no clarification as to who's criteria this referred to. Prioritizing is good. But it is essential to understand the CDC guidelines as distributors of therapeutics. I'm left not knowing if my PCP is aware I should ever receive Evusheld if it becomes more widely available. That is and issue.